glp-1 autoimmune disease and Inflammation: How These Drugs Ease Arthritis For most patients with inflammatory
Description
These bile acids suppress the farnesoid X receptor (FXR) in the intestine
- Those starting GLP-1 medication
* For those taking Wegovy pill, 76% achieved 5% or greater body weight loss (from a baseline body weight of 235 lb) versus 31% taking placebo (from a baseline body weight of 231 lb)
To view a copy of this license, visit About this article Cite this article Chodorge, M., Celeste, A.J., Grimsby, J
Funding This study was supported by Natural Science Foundation of Chongqing (cstc2018jcyjAX0602)
